Studies of ME/CFS patients have found increased CD69 expression on NK cells (40), decreased CD38 (40) or, by comparison to MS patients, increased CD38 and HLA-DR expression on CD8+ T cells (41), suggesting aberrant activation of cytotoxic lymphocytes in ME/CFS patients. The gene discussed is CD69; the disease is myeloid sarcoma.